By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.

Close

Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Close

NICE to assess new ‘debridement pad’ for wounds

A new debridement pad has been developed to help healthcare professionals treat wounds quickly and without analgesia.

The Debrisoft monofilament debridement pad can be wiped across wounds to remove pus, dead cells and other debris that sticks to its monofilament fibres.

According to manufacturers, the single-use polyester fibre pad can treat a wound in just two to four minutes, with no analgesia needed.

They claim the Debrisoft pad can reduce pain associated with debridement when compared with traditional methods such as a scalpel, gauze swabs or jets of water.

By enabling faster treatment of wounds, it could mean fewer nurse visits are necessary and could also reduce the risk of bleeding and trauma to healthy tissue.

It could also cut the cost of treatment, with projected savings of between £99 and £484 per patient.

NICE has now launched a consultation on draft medical technology guidance for Debrisoft.

The draft guidelines support the case for adopting the pad as part of the management of acute or chronic wounds in community settings.

Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!

newsletterpromo